Results 1-20 of 1,142 for speaker:Catherine Ardagh
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Catherine Ardagh: I thank everyone for coming in today. I will look at the 2023 NTPF funding. A lot of people watching the meeting from home will be trying to figure out what insourcing and outsourcing is. I ask the witnesses to break down how much of the 2023 funding was for insourcing and how much was for outsourcing.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Catherine Ardagh: No, I was asking about Beaumont. It was stated that in 2023 Beaumont received €11.4 million from the NTPF. What percentage of that was insourcing and what percentage was outsourcing?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Catherine Ardagh: This is all insourcing.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Catherine Ardagh: That €11.4 million is all insourcing.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Catherine Ardagh: I know my colleague Deputy Dolan spoke about how it is actually patients who are benefiting from this. It is working really well in the majority of hospitals. Mr. Flood outlined that in 35 out of 38 hospitals around the country, it works perfectly. Obviously, there are issues and with every scheme in the country, someone is able to figure out a way to contravene it or go against what it is...
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Catherine Ardagh: It says here that in 2022 the amount spent on the NTPF was €6.6 million. Which department had the biggest increase? Where did the extra €5 million go?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Catherine Ardagh: I am trying to figure out where the bump was. It was a significant bump, with the amount spent on insourcing increasing from €6.6 million to €11.4 million. I am trying to figure out if there was one sector that just decided, "This is great, we will capitalise on it", and was that the sector where we saw issues with governance?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Catherine Ardagh: I thank Mr. Hanlon. My next question might be for Ms Coyle as it is about the total expenditure in the hospital. Obviously, it is a fantastic hospital. It is huge. It does amazing work, especially for the elderly and those with brain injuries. It has a great reputation across the world. At the moment, it seems to be running a deficit. Can Ms Coyle tell me what the situation is? How...
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Catherine Ardagh: There was a deficit in 2023. Obviously, it looked like it was continuing until 2024. Is a further deficit anticipated this year?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Catherine Ardagh: I am going back to insourcing. Sorry, I do not mean to go back to it, but it was mentioned that insourcing will be started again. Why did it take so long to do that?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Catherine Ardagh: Yes. Why is it taking so long to reinstate the insourcing?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Catherine Ardagh: Okay. That is the only reason. How long was it stalled for?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Catherine Ardagh: Deputy Farrelly mentioned issues regarding the board. In 2023, there were only two board meetings, which seems quite peculiar. Does Ms Coyle have any comment on that?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Catherine Ardagh: I understand there were two formal board meetings. Maybe there were meetings without sufficient quorum that were not able to be recorded as formal meetings.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Catherine Ardagh: What is the current make-up of the board? Is there a quorum? Is the board able to have sufficient meetings to ensure proper governance?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Catherine Ardagh: The board meets twice a month.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Catherine Ardagh: So six board meetings per year.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Catherine Ardagh: Okay. Two meetings in 2023 seem quite sparse, from a governance point of view.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Catherine Ardagh: I apologise; Mr. Sweeney is correct. Generally, I have a small question on a clinical matter, namely, the lung cancer screening pilot project. It is something I am interested in. How is that going? Are there plans to make it more permanent and resource it properly? This question is probably for Ms Coyle.